Leap Therapeutics (LPTX)
(Delayed Data from NSDQ)
$2.56 USD
+0.09 (3.64%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $2.56 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.46 |
EPS Last Quarter | -0.52 |
Last EPS Surprise | -23.81% |
ABR | 1.20 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.84 |
Next Year | -1.36 |
EPS (TTM) | -2.00 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.46 | -0.37 | -1.84 | -1.36 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.37 | -0.31 | -1.68 | -1.21 |
High Estimate | -0.37 | -0.31 | -1.68 | -1.21 |
Low Estimate | -0.52 | -0.40 | -1.94 | -1.56 |
Year ago EPS | -0.51 | -0.46 | -3.98 | -1.84 |
Year over Year Growth Est. | 9.80% | 19.57% | 53.77% | 26.45% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 2 | 0 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 1 | 3 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.46 | -0.37 | -1.84 | -1.36 |
7 Days Ago | -0.46 | -0.37 | -1.84 | -1.36 |
30 Days Ago | -0.46 | -0.37 | -1.84 | -1.36 |
60 Days Ago | -0.39 | -0.38 | -1.66 | -1.48 |
90 Days Ago | -0.39 | -0.38 | -1.66 | -1.48 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.46 | -0.37 | -1.84 | -1.36 |
Zacks Consensus Estimate | -0.46 | -0.37 | -1.84 | -1.36 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.52 | -0.51 | -0.46 | -0.51 | NA |
Estimate | -0.42 | -0.57 | -0.56 | -0.48 | NA |
Difference | -0.10 | 0.06 | 0.10 | -0.03 | 0.01 |
Surprise | -23.81% | 10.53% | 17.86% | -6.25% | -0.42% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more